Skip to content
The Policy Vault
Methodology
Why
Contact
Coverage
/
Medica
/
tetrabenazine
/
Tourette syndrome
← Back
tetrabenazine — Medica
Tourette syndrome
Initial criteria
Patient age ≥ 18 years
Medication is prescribed by or in consultation with a neurologist
Approval duration
1 year